title: Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra.
authors.forename: Matteo
authors.initials: M
authors.lastname: Colina
authors.forename: Cinzia
authors.initials: C
authors.lastname: Pizzirani
authors.forename: Micheline
authors.initials: M
authors.lastname: Khodeir
authors.forename: Simonetta
authors.initials: S
authors.lastname: Falzoni
authors.forename: Marco
authors.initials: M
authors.lastname: Bruschi
authors.forename: Francesco
authors.initials: F
authors.lastname: Trotta
authors.forename: Francesco
authors.initials: F
authors.lastname: Di Virgilio
mesh_terms: D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008875:Middle Aged; D058486:Receptors, Purinergic P2X7 / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D058486:Receptors, Purinergic P2X7